首页|沙利度胺超适应证应用价值分析

沙利度胺超适应证应用价值分析

扫码查看
目的 统计分析医院超适应证使用沙利度胺的用药情况,为医师、药师和患者应用沙利度胺提供参考。方法 收集医院 2022 年1 月~2022 年 12 月使用沙利度胺的门诊处方,均为超适应证用药处方。引用Micromedex数据库的 Thomson分级系统中的证据强度分级,以疾病诊断和沙利度胺为关键词查询数据库,判定超适应证使用沙利度胺有无用药证据。结果 沙利度胺超适应证使用有据可查的疾病包括多发性骨髓瘤、淋巴瘤、强直性脊柱炎、类风湿性关节炎、系统性红斑狼疮、白塞病、结缔组织病、溃疡性结肠炎、过敏性紫癜、皮肌炎、湿疹。无证据支持沙利度胺用于带状疱疹。结论 门诊患者超适应证使用沙利度胺均有证据支持,带状疱疹除外,治疗安全有效。
The value of off-indication use of thalidomide
Objective To statistically analyze the off-indication use of thalidomide in hospital and provide reference for doctors,pharmacists and patients to use thalidomide.Methods Outpatient prescriptions of thalidomide used in hospital from January 2022 to December 2022 were collected.The evidence intensity classification in Thomson grading system of Micromedex database was cited,and the database was queried with di-agnosis and thalidomide as keywords to determine the presence or absence of evidence-based medical evidence for off-indication use of thalidomide.Results The off-indication use of thalidomide involved diagnoses including multiple myeloma(MM),lymphoma,ankylosing spondylitis(AS),rheumatoid arthritis(RA),systemic lupus erythematosus(SLE),Behcet's disease,connective tissue disease,ulcerative colitis(UC),allergic purpura,dermatomyositis and eczema.There is no evidence to support thalidomide for herpes zoster.Conclusion There are evidences to support the off-indication use of thalidomide in outpatients,except herpes zoster.It is safe and effective for treatment.

ThalidomideOff-indicationMultiple myelomaRheumatoid arthritisSystemic lupus erythematosusAnkylosing spondylitis

张丽琼、林柳任

展开 >

曲靖市第二人民医院药学部,云南曲靖 655000

沙利度胺 超适应证 多发性骨髓瘤 类风湿性关节炎 系统性红斑狼疮 强直性脊柱炎

2024

中国处方药
南方医药经济研究所

中国处方药

影响因子:0.649
ISSN:1671-945X
年,卷(期):2024.22(6)